Register Now for our January 14th Webinar on Spinal Stimulation and the Onward ARC-EX
Photo courtesy of ONWARD
Beyond the Headlines: A Real-World Understanding of Spinal Cord Stimulation and the Onward ARC-EX
Zoom Webinar presented by NorCal SCI & Neuroworx
Transcutaneous Spinal Stimulation (TSS) has gained significant attention as a potential intervention for individuals with spinal cord injury. With the recent release of the ONWARD ARC-EX device and its FDA approval for in-home use, many people with SCI are now exploring TSS.
We know there’s a lot of excitement about TSS, the Onward ARC-EX and its potential to improve function post SCI. That’s why NorCal SCI will be hosting a webinar focused on educating and informing the SCI community about these technologies as we hope that people can learn as much as possible before they try TSS or decide to purchase an Onward ARC-EX device.
This webinar will provide an evidence-informed, balanced overview of the current state of TSS. Presenters will review the research foundations that led to today’s clinical and commercial devices, compare clinically available and experimental systems, and share case examples demonstrating real-world outcomes with clinic-based TSS. We will then provide personal perspectives from individuals with SCI who have experience using ARC-EX and other TSS devices.
Presenters hope to support informed decision-making by presenting the data, clinical realities, and lived experiences. There will be a Q&A at the end so show up with your questions!
Register HERE for the webinar and mark your calendars. You won’t want to miss this unique event!
Wednesday January 14th 3-430pm PST
Zoom - Meeting details will be sent to registrants
Webinar Presenters:
Emma Buckley, PT, DPT
is a physical therapist at Neuroworx, specializing in spinal cord injury rehabilitation. She has over three years of experience using transcutaneous spinal stimulation (TSS) in clinical practice and as an interventionist in FDA-regulated trials, providing a practical perspective on both the promise and limitations of currently available stimulation technologies.
Kyle Byrnes, OTD, OTR/L
is a research administrator and occupational therapist at Neuroworx. He oversees clinical research operations, program development, and clinical outcomes tracking, and served as a site Principal Investigator for the ASPIRE Clinical Trial. His work focuses on bridging research and clinical practice, evaluating real-world effectiveness of emerging neurotechnology, and expanding access to evidence-based rehabilitation for individuals with neurological injuries.